Page-4 of COVAXIN

India-Bangladesh sign MoU on COVID-19 Vaccine

On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights ..

Month: 

EpicVacCorona: Second COVID-19 Vaccine approved by Russia

The Russian Authorities have approved a new COVID-19 vaccine called “EpicVacCorona”. It is a two shot vaccine. Key Highlights EpiVacCorona is a peptide-based vaccine. Sputnik V was the first vaccine developed by Russia. Russia is to conduct the vaccine trial ..

Month: 

COVAXIN to use Alhydroxiquim-II to boost Immune Response

The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has sought the approval of Drugs Controller General of India to begin phase ..

Month: 

COVID-19 Vaccine: Serum Institute of India to produce additional 100 million doses for India

The Serum Institute of India recently announced that it will produce additional 100 million COVID-19 vaccines for low- and middle- income countries by 2021. Highlights Earlier, the institute had committed to deliver 100 million vaccines. Now a total of 200 ..

Month: 

ICMR to allow COVID-19 vaccines with 50% efficacy

The Indian Council for Medical Research approves COVID-19 vaccines with 50-100% efficacy. According to ICMR, no respiratory vaccines have 100% efficacy. Highlights According to the World Health Organization, a vaccine should have three things namely safety, efficacy and immunogenicity. Immunogenicity ..

Month: 

What Immunization Programme Mechanism will GoI use to distribute COVID-19 vaccines?

The Government of India is to use the Universal Immunization Programme mechanism to distribute covid-19 vaccines in the country. This was announced by the Union Health Minister Harsh Vardhan during his address in the Lok Sabha. Universal Immunization Programme Under ..

Month: 

Dr. Dangs Lab to Partner with Bharat Biotech for Human Trials of Covaxin

The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as the first-ever indigenous vaccine developed by Bharat Biotech in collaboration with the ..

Month: 

AIIMS Panel Gives Nod for Covaxin Human Trials

The Ethics Committee of the All India Institute of Medical Sciences (AIIMS) has given the approval to start the human trials for the indigenously developed COVID 19 vaccine, Covaxin. The premier hospital is expected to start the trial from July ..

Month: